Fig. 6From: Immune checkpoint inhibitors in Cancer patients with rheumatologic preexisting autoimmune diseases: a systematic review and meta-analysisPooled effect estimates for ICI-treated patients with rheumatologic PAD: (A) ORR; (B) DCR. ORR: objective response rate; DCR: disease control rateBack to article page